In clinical virology, detecting Hepatitis B virus (HBV) during early window periods requires diagnostic solutions that leave zero room for ambiguity.When viral titers are low, Nucleic Acid Testing (NAT) via real-time PCR provides the definitive analytical sensitivity needed to ensure clinical diagnostic accuracy and donor blood safety.The NeoDx HBV Qualitative RT-PCR Detection Kit is engineered specifically for high-throughput, quality-conscious molecular diagnostic laboratories:🔹 Standardized Sensitivity: Analytical LoD of 32 IU/mL (~179.2 Copies/mL), calibrated directly against the 4th WHO International Standard (NIBSC 10/266).🔹 Dual-Target Assurance: Single-tube multiplex assay utilizing TaqMan fluorescent probes with an integrated human Beta-Actin internal control to verify extraction integrity and prevent false negatives caused by PCR inhibitors.🔹 Open-Platform Flexibility: Fully validated across routine real-time PCR platforms (Bio-Rad CFX96, Applied Biosystems QuantStudio, Rotor-Gene Q, etc.).🔹 Optimized Workflow: Complete thermal cycling run in ~90 minutes across serum, plasma, and whole blood matrices.🔹 Regulatory Compliance: CDSCO-approved in vitro diagnostic (IVD) kit.Help your lab combine molecular precision with operational efficiency.📥 Access full product parameters, performance data, and inquiry options here:👉
https://www.neodx.in/hepatitis-b-screening-real-time-pcr-detection#MolecularDiagnostics #IVD #Pathology #HepatitisB #RealTimePCR #ClinicalVirology #LaboratoryMedicine #NeoDx #BiotechIndia #BloodSafetyIn clinical virology, detecting Hepatitis B virus (HBV) during early window periods requires diagnostic solutions that leave zero room for ambiguity.When viral titers are low, Nucleic Acid Testing (NAT) via real-time PCR provides the definitive analytical sensitivity needed to ensure clinical diagnostic accuracy and donor blood safety.The NeoDx HBV Qualitative RT-PCR Detection Kit is engineered specifically for high-throughput, quality-conscious molecular diagnostic laboratories:🔹 Standardized Sensitivity: Analytical LoD of 32 IU/mL (~179.2 Copies/mL), calibrated directly against the 4th WHO International Standard (NIBSC 10/266).🔹 Dual-Target Assurance: Single-tube multiplex assay utilizing TaqMan fluorescent probes with an integrated human Beta-Actin internal control to verify extraction integrity and prevent false negatives caused by PCR inhibitors.🔹 Open-Platform Flexibility: Fully validated across routine real-time PCR platforms (Bio-Rad CFX96, Applied Biosystems QuantStudio, Rotor-Gene Q, etc.).🔹 Optimized Workflow: Complete thermal cycling run in ~90 minutes across serum, plasma, and whole blood matrices.🔹 Regulatory Compliance: CDSCO-approved in vitro diagnostic (IVD) kit.Help your lab combine molecular precision with operational efficiency.📥 Access full product parameters, performance data, and inquiry options here:👉 https://www.neodx.in/hepatitis-b-screening-real-time-pcr-detection#MolecularDiagnostics #IVD #Pathology #HepatitisB #RealTimePCR #ClinicalVirology #LaboratoryMedicine #NeoDx #BiotechIndia #BloodSafety
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek